Teradyne, Inc (TER) concluded trading on Wednesday at a closing price of $94.18, with 4.28 million shares of worth about $403.26 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -26.73% during that period and on July 02, 2025 the price saw a gain of about 2.46%. Currently the company’s common shares owned by public are about 160.67M shares, out of which, 159.97M shares are available for trading.
Stock saw a price change of 4.41% in past 5 days and over the past one month there was a price change of 18.48%. Year-to-date (YTD), TER shares are showing a performance of -36.49% which decreased to -25.21% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $65.77 but also hit the highest price of $163.21 during that period. The average intraday trading volume for Teradyne, Inc shares is 3.49 million. The stock is currently trading 7.49% above its 20-day simple moving average (SMA20), while that difference is up 14.76% for SMA50 and it goes to -10.32% lower than SMA200.
Teradyne, Inc (NASDAQ: TER) currently have 160.67M outstanding shares and institutions hold larger chunk of about 98.68% of that.
The stock has a current market capitalization of $15.11B and its 3Y-monthly beta is at 1.70. PE ratio of stock for trailing 12 months is 26.66, while it has posted earnings per share of $3.53 in the same period. Its PEG reads 1.33 and has Quick Ratio of 1.61 while making debt-to-equity ratio of 0.02. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TER, volatility over the week remained 2.51% while standing at 2.87% over the month.
Stock’s fiscal year EPS is expected to drop by -0.68% while it is estimated to increase by 41.36% in next year. EPS is likely to grow at an annualized rate of 20.11% for next 5-years, compared to annual growth of 4.98% made by the stock over the past 5-years.
Coverage by TD Cowen stated Teradyne, Inc (TER) stock as a Buy in their note to investors on March 12, 2025, suggesting a price target of $110 for the stock. On March 07, 2025, Vertical Research Initiated their recommendations, while on January 21, 2025, Morgan Stanley Downgrade their ratings for the stock with a price target of $117. Stock get an Outperform rating from Northland Capital on January 06, 2025.
